X4 Pharmaceuticals, Inc.
Key Metrics
Market Snapshot
About
X4 Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for rare diseases and cancer. The company specializes in targeting the CXCR4 pathway, with lead product candidate mavorixafor designed to treat WHIM syndrome and other conditions. X4 Pharmaceuticals is advancing precision medicine approaches for patients with limited treatment options.